RecruitingNot ApplicableNCT06309017

Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease


Sponsor

NYU Langone Health

Enrollment

150 participants

Start Date

Jan 7, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to determine if improved risk stratification tools and interventions to mitigate malnutrition reduce postoperative risk in patients undergoing elective or emergent resection surgery for inflammatory bowel disease (IBD), and if adding immune modulation nutrition improves surgical outcomes. The primary objective is to assess whether preoperative malnutrition screening and intervention minimize postoperative complications. The secondary objective is to evaluate whether immune modulation nutrition in the peri-operative period decreases length of stay and major complications.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Able and willing to provide written informed consent
  • Aged 18 years of age or older
  • Confirmed diagnosis of inflammatory bowel disease
  • Scheduled for disease-related intestinal resection at NYU Langone Health

Exclusion Criteria3

  • No current diagnosis of inflammatory bowel disease
  • Age less than 18
  • Not proficient (able to read and answer questions) in English

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNutrition specialist

Nutrition specialist to help improve nutritional status by diet, oral nutrition supplements or parenteral nutrition.

DIETARY_SUPPLEMENTEnsure Surgery Immunonutrition shakes

All study subjects, including subjects without malnutrition, will be given the Ensure Surgery Immunonutrition Shakes for prior to surgery as per standard of care. All subjects will also receive additional shakes starting as an inpatient when diet is advanced.


Locations(1)

NYU Langone Health

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06309017


Related Trials